These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 17253535)

  • 41. Propylthiouracil for alcoholic liver disease.
    Rambaldi A; Gluud C
    Cochrane Database Syst Rev; 2002; (2):CD002800. PubMed ID: 12076451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Efficacy of antioxidants in treatment of nonalcoholic fatty liver: a systematic review].
    Zeng M; Wang Y; Wu L
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 May; 32(5):695-702. PubMed ID: 22588928
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dietary supplements for chronic gout.
    Andrés M; Sivera F; Falzon L; Buchbinder R; Carmona L
    Cochrane Database Syst Rev; 2014 Oct; (10):CD010156. PubMed ID: 25287939
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glucocorticosteroids for primary sclerosing cholangitis.
    Giljaca V; Poropat G; Stimac D; Gluud C
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD004036. PubMed ID: 20091555
    [TBL] [Abstract][Full Text] [Related]  

  • 45. D-penicillamine for primary biliary cirrhosis.
    Gong Y; Frederiksen SL; Gluud C
    Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD004789. PubMed ID: 15495127
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of vitamin E supplementation on aminotransferase levels in patients with NAFLD, NASH, and CHC: results from a meta-analysis.
    Ji HF; Sun Y; Shen L
    Nutrition; 2014 Sep; 30(9):986-91. PubMed ID: 24976430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bile acids for viral hepatitis.
    Chen W; Liu J; Gluud C
    Cochrane Database Syst Rev; 2003; (2):CD003181. PubMed ID: 12804455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological interventions for acute hepatitis C infection: an attempted network meta-analysis.
    Kalafateli M; Buzzetti E; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011644. PubMed ID: 28285495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aminoadamantanes for chronic hepatitis C.
    Lamers MH; Broekman M; Drenth JP; Gluud C
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD010125. PubMed ID: 24793264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.
    Rambaldi A; Jacobs BP; Iaquinto G; Gluud C
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003620. PubMed ID: 15846671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
    Rudic JS; Giljaca V; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2011 Dec; (12):CD009144. PubMed ID: 22161446
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis.
    Rambaldi A; Gluud C
    Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD002148. PubMed ID: 15846629
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease.
    Del Ben M; Polimeni L; Baratta F; Pastori D; Angelico F
    Br J Clin Pharmacol; 2017 Jan; 83(1):88-95. PubMed ID: 26852185
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases.
    Riemsma RP; Bala MM; Wolff R; Kleijnen J
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009498. PubMed ID: 23633373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases.
    Riemsma RP; Bala MM; Wolff R; Kleijnen J
    Cochrane Database Syst Rev; 2012 Sep; (9):CD009498. PubMed ID: 22972145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.
    He XX; Wu XL; Chen RP; Chen C; Liu XG; Wu BJ; Huang ZM
    PLoS One; 2016; 11(10):e0162368. PubMed ID: 27711128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vitamin E and nonalcoholic fatty liver disease.
    Pacana T; Sanyal AJ
    Curr Opin Clin Nutr Metab Care; 2012 Nov; 15(6):641-8. PubMed ID: 23075940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease.
    Musso G; Gambino R; Cassader M; Pagano G
    Hepatology; 2010 Jul; 52(1):79-104. PubMed ID: 20578268
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bile acids for primary sclerosing cholangitis.
    Chen W; Gluud C
    Cochrane Database Syst Rev; 2003; (2):CD003626. PubMed ID: 12804480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease.
    Vadarlis A; Antza C; Bakaloudi DR; Doundoulakis I; Kalopitas G; Samara M; Dardavessis T; Maris T; Chourdakis M
    J Gastroenterol Hepatol; 2021 Feb; 36(2):311-319. PubMed ID: 32810309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.